Gold LS, Weiss JS, Green L, Kircik L, Miller L, Jacobson A, Harris S. Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients with Baseline Body Surface Area of 6 -12%. J of Skin [Internet]. 2020Sep.2 [cited 2024Jul.3];4(5):s37. Available from: https://jofskin.org/index.php/skin/article/view/986